JUN 27, 2017 8:00 AM PDT

WEBINAR: Investigating the Genetics of Human Macrophage Response and Resistance to Mycobacterium tuberculosis with AmpliSeq™ Gene Expression Panels

Speaker

Abstract

DATE: June 27, 2017
TIME: 8:00am PT, 11:00am ET

The purpose of this study is to identify genetic variants that influence cellular responses, and patterns of M.tb infection and growth in human alveolar macrophages.

We used next-generation RNA sequencing, and DNA genotyping to identify candidate genes and gene networks, reveal operative genetic variants and address genotype-RNA-cellular phenotype relationships in M.tb-infected human alveolar macrophage cultures on a genome-wide scale. The Ion AmpliSeq transcriptome assay enables highly sensitive and reproducible measurement of differential gene expression, facilitating downstream enables highly sensitive and reproducible measurement of differential gene expression, facilitating downstream network and component analysis. We follow up with custom designed AmpliSeq allelic expression assays on a selection of high priority genes, to quantitatively measure effects on expression, and characterize causal variants in individual donors. We then test the health related effects of these functional variants in existing human genome wide association studies of tuberculosis related phenotypes. Our overarching goal is to use this specific genetic and phenotypic information to guide tuberculosis vaccine development, and to better predict individual response.

  • How to improve biomarker discovery using NGS
  • Benefits of applying a targeted gene-expression based approach for studying genotype-RNA-cellular phenotype relationships
  • How to implement the Ion AmpliSeq Human Transcriptome Gene Expression assay to guide vaccine development and predict individual response.

For Research Only. Not for use in diagnostic procedures.


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
JUN 27, 2017 8:00 AM PDT

WEBINAR: Investigating the Genetics of Human Macrophage Response and Resistance to Mycobacterium tuberculosis with AmpliSeq™ Gene Expression Panels



Show Resources
Loading Comments...
Show Resources